IMPROVEMENT OF MEMORY IN PATIENTS WITH AN ESTIMATION OF 24-26 SCORES BY THE SHORT SCALE OF THE ASSESSMENT OF THE MENTAL STATUS

摘要

1. The use of a composition comprising: a. uridine or uridine phosphate; and b. docosahexaenoic acid and / or eicosapentaenoic acid to obtain a product to improve memory and / or treat or prevent impaired memory function, preferably in a subject with 24, 25 or 26 points on a brief scale for assessing mental status in which the composition is administered to the patient. 2. The use of claim 1, wherein said patient has not received drug therapy. The use according to claim 1 or 2, for (i) improving the function of delayed recall and / or (ii) treatment and / or prevention of impaired function of delayed recall in a patient (subject) with 24-26 points on a short scale for assessing mental status. 4. The use according to claim 1 or 2, wherein the composition contains phospholipids, choline, vitamin E, vitamin C, selenium, vitamin B12, vitamin B6 and folic acid. The use according to claim 1 or 2, wherein the composition is administered to the patient enterally at least once a day for a period of at least 3 weeks. The use according to claim 1 or 2, wherein the composition contains 0.1-2 g of uridine, calculated as uridine monophosphate, per daily unit dose, and 400-5000 mg in total of DHA and EPA per daily unit dose. The use according to claim 1 or 2, where the composition contains from 1 to 50 g of easily digestible carbohydrates per 100 ml, 0.5-10 g of protein per 100 ml and 0.2-3 kcal / ml. The use according to claim 1 or 2, wherein the composition is a liquid composition having a viscosity of 1 to 100 mPz, measured at a shear rate of 100 at 20 ° C.